Qi Zeng

779 total citations
17 papers, 541 citations indexed

About

Qi Zeng is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Qi Zeng has authored 17 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Qi Zeng's work include Protein Tyrosine Phosphatases (4 papers), Galectins and Cancer Biology (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Qi Zeng is often cited by papers focused on Protein Tyrosine Phosphatases (4 papers), Galectins and Cancer Biology (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Qi Zeng collaborates with scholars based in China, Singapore and United States. Qi Zeng's co-authors include Y.H. Tan, Ke Guo, Bin Gan, Jing Tang, Jie Li, Xiaoan Tao, Bin Cheng, Fang Huang, Jie Li and Jing Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Qi Zeng

17 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qi Zeng China	10	414	169	91	91	32	17	541
Heng-Yi Chen Taiwan	8	193 0.5×	283 1.7×	89 1.0×	43 0.5×	46 1.4×	16	490
Zhiguang Fu China	11	419 1.0×	145 0.9×	97 1.1×	119 1.3×	24 0.8×	17	571
Armin Ahmadi United States	12	233 0.6×	153 0.9×	126 1.4×	35 0.4×	18 0.6×	23	511
Xianming Kong China	14	277 0.7×	64 0.4×	84 0.9×	108 1.2×	31 1.0×	24	558
Kun Xie China	12	676 1.6×	43 0.3×	131 1.4×	313 3.4×	16 0.5×	20	856
Oscar W.H. Yeung Hong Kong	8	205 0.5×	336 2.0×	197 2.2×	124 1.4×	21 0.7×	12	635
Yongjiang Zheng China	11	396 1.0×	78 0.5×	64 0.7×	234 2.6×	14 0.4×	21	577
Zhanxue Xu China	11	370 0.9×	122 0.7×	62 0.7×	170 1.9×	13 0.4×	21	560
Shiqiang Zhang China	13	128 0.3×	51 0.3×	71 0.8×	50 0.5×	12 0.4×	30	404
Meixiao Zhan China	9	161 0.4×	59 0.3×	79 0.9×	87 1.0×	6 0.2×	13	306

Countries citing papers authored by Qi Zeng

Since Specialization

Citations

This map shows the geographic impact of Qi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zeng more than expected).

Fields of papers citing papers by Qi Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zeng. The network helps show where Qi Zeng may publish in the future.

Co-authorship network of co-authors of Qi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Zeng. A scholar is included among the top collaborators of Qi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Zeng. Qi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zeng, Qi, Yao Chen, Shimeng Zhang, et al.. (2024). ORMDL3 restrains type I interferon signaling and anti-tumor immunity by promoting RIG-I degradation. eLife. 13. 1 indexed citations

Hu, Yan, Mingwei Huang, Jian Gao, et al.. (2023). Case report: splicing effect of a novel heterozygous variant of the NUS1 gene in a child with epilepsy. Frontiers in Genetics. 14. 1224949–1224949. 3 indexed citations

Peng, Ling, et al.. (2021). Functional Analysis of Ectodysplasin-A Mutations in X-Linked Nonsyndromic Hypodontia and Possible Involvement of X-Chromosome Inactivation. Stem Cells International. 2021. 1–10. 4 indexed citations

Wang, Rui, et al.. (2021). A light-activatable antibiotic with high activation efficiency and uncompromised bactericidal potency in the activated state. SHILAP Revista de lepidopterología. 3(1). 6 indexed citations

Li, Jingzhou, et al.. (2020). Melatonin-induced suppression of DNA methylation promotes odontogenic differentiation in human dental pulp cells. Bioengineered. 11(1). 829–840. 22 indexed citations

Wang, Xudong, Qi Zeng, Lianbo Li, et al.. (2020). The p38‐interacting protein p38IP suppresses TCR and LPS signaling by targeting TAK1. EMBO Reports. 21(7). e48035–e48035. 11 indexed citations

Zeng, Qi, Yimin Liu, Jun Liu, et al.. (2019). Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells. Cell Death and Disease. 10(8). 588–588. 30 indexed citations

Pan, Siyu, Jinming Chang, Zhou Xu, et al.. (2019). A potentially general approach to aliphatic ester-derived PVC plasticizers with suppressed migration as sustainable alternatives to DEHP. Green Chemistry. 21(23). 6430–6440. 40 indexed citations

Zeng, Qi, et al.. (2018). [Genotype-phenotype correlation in patients with alternating hemiplegia of childhood].. PubMed. 56(11). 811–817. 6 indexed citations

10.

Zeng, Qi, Xi Yang, Xiaobing Chen, et al.. (2017). Porphyromonas gingivalis lipopolysaccharide induces over production of CC chemokine ligand 2 via toll‐like receptor‐4 in oral lichen planus. Journal of Oral Pathology and Medicine. 47(2). 166–172. 13 indexed citations

11.

Chang, Jinming, Yi Chen, Zhou Xu, et al.. (2017). Switchable Control of Antibiotic Activity: A Shape-Shifting “Tail” Strategy. Bioconjugate Chemistry. 29(1). 74–82. 9 indexed citations

12.

Zeng, Qi, Xiaoan Tao, Fang Huang, et al.. (2016). Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2. International Journal of Molecular Medicine. 37(5). 1274–1280. 54 indexed citations

13.

Yin, Jingfang, et al.. (2015). The positive correlation of theCCL2‐CCR2 axis with the disease activity may indicate the fundamental role in the pathogenesis of oral lichen planus. Journal of Oral Pathology and Medicine. 45(1). 41–47. 7 indexed citations

14.

Guo, Ke, Jing Tang, Abdul Qader Al-Aidaroos, et al.. (2012). Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice. Oncotarget. 3(2). 158–171. 44 indexed citations

15.

Li, Jie, Ke Guo, Jing Tang, et al.. (2005). Generation of PRL-3- and PRL-1-Specific Monoclonal Antibodies as Potential Diagnostic Markers for Cancer Metastases. Clinical Cancer Research. 11(6). 2195–2204. 54 indexed citations

16.

Guo, Ke, et al.. (2004). Catalytic domain of PRL-3 plays an essential role in tumor metastasis: Formation of PRL-3 tumors inside the blood vessels. Cancer Biology & Therapy. 3(10). 945–951. 78 indexed citations

17.

Zeng, Qi, et al.. (1998). Mouse PRL-2 and PRL-3, Two Potentially Prenylated Protein Tyrosine Phosphatases Homologous to PRL-1. Biochemical and Biophysical Research Communications. 244(2). 421–427. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact